Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

Attorneys say the FDA is unlikely to challenge the court’s decision, though Congress could still look to modernize lab test ...

CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.